LADENBURG THALMANN FINANCIAL SERVICES INC. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 200 filers reported holding SAGE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.86 and the average weighting 0.3%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$56,000
-27.3%
771
+40.2%
0.00%
-100.0%
Q3 2019$77,000
-78.1%
550
-71.4%
0.00%
-66.7%
Q2 2019$351,000
+457.1%
1,922
+380.5%
0.00%
Q1 2019$63,000
+96.9%
400
+19.8%
0.00%
Q4 2018$32,000
-60.5%
334
-41.2%
0.00%
-100.0%
Q3 2018$81,000
+11.0%
568
+24.0%
0.00%0.0%
Q2 2018$73,0000.0%4580.0%0.00%0.0%
Q1 2018$73,000
+15.9%
458
+19.9%
0.00%0.0%
Q4 2017$63,000
+6200.0%
382
+2022.2%
0.00%
Q3 2017$1,0000.0%18
+63.6%
0.00%
Q2 2017$1,0000.0%110.0%0.00%
Q1 2017$1,0000.0%110.0%0.00%
Q4 2016$1,0000.0%110.0%0.00%
Q3 2016$1,00011
-31.2%
0.00%
Q2 2016$0
-100.0%
160.0%0.00%
Q1 2016$1,000
-50.0%
16
-52.9%
0.00%
Q4 2015$2,000
+100.0%
34
+78.9%
0.00%
Q3 2015$1,0000.0%190.0%0.00%
Q2 2015$1,000190.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders